Поиск

Выпуск
Название
Авторы
Том 23, № 14 (2023)
Diosgenin Glucoside Inhibits the Progression of Osteosarcoma MG-63 by Regulating the PI3K/AKT/mTOR Pathway
Ruan S., Gu L., Wang Y., Huang X., Cao H.
PDF
(Eng)
Том 14, № 6 (2014)
Design and Development of Oxazol-5-Ones as Potential Partial PPAR-γ Agonist Against Cancer Cell Lines
Pal T., Joshi H., Ramaa C.
PDF
(Eng)
Том 13, № 7 (2013)
Targeting the PI3K/Akt/mTOR Axis by Apigenin for Cancer Prevention
Tong X., Pelling J.
PDF
(Eng)
Том 10, № 6 (2010)
Therapeutic Exploitation of Apoptosis and Autophagy for Glioblastoma
Kogel D., Fulda S., Mittelbronn M.
PDF
(Eng)
Том 24, № 18 (2024)
The Role of Serine Protease 8 in Mediating Gefitinib Resistance in Non-small Cell Lung Cancer
Gao H., Geng X., Wang L., Zhao C., Liang Z., Xing E.
PDF
(Eng)
Том 14, № 5 (2014)
Advances in the Researches on the Biological Activities and Inhibitors of Phosphatidylinositol 3-kinase
Tang J., Wen Q., Sun J., Zhang W., Zhu H.
PDF
(Eng)
Том 13, № 2 (2013)
Metformin: A Rising Star to Fight the Epithelial Mesenchymal Transition in Oncology
Barriere G., Tartary M., Rigaud M.
PDF
(Eng)
Том 25, № 13 (2025)
Effects of Citrus-derived Diosmetin on Melanoma: Induction of Apoptosis and Autophagy Mediated by PI3K/Akt/mTOR Pathway Inhibition
Li j., Xu M., Wu N., Wu F., Chen J., Xu X., Tan F., Liu Y.
PDF
(Eng)
Том 24, № 17 (2024)
Arnicolide D Inhibits Proliferation and Induces Apoptosis of Osteosarcoma Cells through PI3K/Akt/mTOR Pathway
Chen Z., Ni R., Hu Y., Yang Y., Tian Y.
PDF
(Eng)
Том 13, № 7 (2013)
Targeting mTOR: Evaluating the Therapeutic Potential of Resveratrol for Cancer Treatment
Wu Y., Liu F.
PDF
(Eng)
Том 12, № 6 (2012)
Current and Emerging Strategies in Bladder Cancer
Carradori S., Cristini C., Secci D., Gulia C., Gentile V., Battista Di Pierro G.
PDF
(Eng)
Том 23, № 9 (2023)
Synthetic Methodologies and SAR of Quinazoline Derivatives as PI3K Inhibitors
Raj A., Kumar A., Singh A., Singh H., Thareja S., Kumar P.
PDF
(Eng)
Том 16, № 2 (2016)
Indole Derivatives as Anticancer Agents for Breast Cancer Therapy: A Review
Sidhu J., Singla R., Mayank , Jaitak V.
PDF
(Eng)
Том 13, № 7 (2013)
Inhibition of mTOR Signaling by Quercetin in Cancer Treatment and Prevention
Bruning A.
PDF
(Eng)
Том 11, № 9 (2011)
Regulation of Autophagy by Sphingolipids
Bedia C., Levade T., Codogno P.
PDF
(Eng)
Том 23, № 17 (2023)
Targeting Glutamine Metabolism through Glutaminase Inhibition Suppresses Cell Proliferation and Progression in Nasopharyngeal Carcinoma
Su C., Li M., Yang Y., Wang Z., Wang Q., Wang W., Ma X., Jie R., Chen H., Li X., Lu J.
PDF
(Eng)
Том 16, № 1 (2016)
Nutrition, Nitrogen Requirements, Exercise and Chemotherapy-Induced Toxicity in Cancer Patients. A puzzle of Contrasting Truths?
Flati V., Corsetti G., Pasini E., Rufo A., Romano C., Dioguardi F.
PDF
(Eng)
Том 13, № 7 (2013)
Deregulation of PI3K/Akt/mTOR Signaling Pathways by Isoflavones and its Implication in Cancer Treatment
Ahmad A., Biersack B., Li Y., Kong D., Bao B., Schobert R., Padhye S., Sarkar F.
PDF
(Eng)
Том 11, № 6 (2011)
Targeting Receptor Tyrosine Kinase Pathways in Hepatocellular Carcinoma
Wen Chong L., Anh Tuan Luu D., Tzen Jong C., Wei Ling Lam I., Huynh H., Wei Jie Ong R., Yi Qing Li P., Shean Lee S., Yang S.
PDF
(Eng)
Том 16, № 1 (2016)
Potential Molecular Targeted Therapeutics: Role of PI3-K/Akt/mTOR Inhibition in Cancer
Sokolowski K., Koprowski S., Kunnimalaiyaan S., Balamurugan M., Gamblin T., Kunnimalaiyaan M.
PDF
(Eng)
Том 13, № 7 (2013)
Inhibition of Akt/mTOR Signaling by the Dietary Flavonoid Fisetin
Syed D., Adhami V., Khan M., Mukhtar H.
PDF
(Eng)
Том 11, № 5 (2011)
Targeting Phosphoinositide 3-Kinase Pathways in Pancreatic Cancer – from Molecular Signalling to Clinical Trials
Falasca M., Selvaggi F., Buus R., Sulpizio S., E. Edling C.
PDF
(Eng)
Том 23, № 13 (2023)
Triptolide Induces Apoptosis and Autophagy in Cutaneous Squamous Cell Carcinoma via Akt/mTOR Pathway
Zheng Z., Yan G., Xi N., Xu X., Zeng Q., Wu Y., Zheng Y., Zhang G., Wang X.
PDF
(Eng)
Том 15, № 6 (2015)
Ligustrazine Suppresses the Growth of HRPC Cells through the Inhibition of Cap- Dependent Translation Via Both the mTOR and the MEK/ERK Pathways
Han J., Song J., Li X., Zhu M., Guo W., Xing W., Zhao R., He X., Liu X., Wang S., Li Y., Huang H., Xu X.
PDF
(Eng)
Том 13, № 7 (2013)
Hitting the Golden TORget: Curcumin's Effects on mTOR Signaling
Beevers C., Zhou H., Huang S.
PDF
(Eng)
Том 11, № 5 (2011)
Insulin-Like Growth Factor Signaling as a Therapeutic Target in Pancreatic Cancer
Rieder S., W. Michalski C., Friess H., Kleeff >.
PDF
(Eng)
Том 24, № 6 (2024)
Cryptolepine Analog Exhibits Antitumor Activity against Ehrlich Ascites Carcinoma Cells in Mice via Targeting Cell Growth, Oxidative Stress, and PTEN/Akt/mTOR Signaling Pathway
El-Aarag B., Shalaan E., Ahmed A., El Sayed I., Ibrahim W.
PDF
(Eng)
Том 14, № 6 (2014)
miR-1271 Regulates Cisplatin Resistance of Human Gastric Cancer Cell Lines by Targeting IGF1R, IRS1, mTOR, and BCL2
Yang M., Shan X., Zhou X., Qiu T., Zhu W., Ding Y., Shu Y., Liu P.
PDF
(Eng)
Том 13, № 7 (2013)
Molecular Evidence of Cryptotanshinone for Treatment and Prevention of Human Cancer
Chen W., Lu Y., Chen G., Huang S.
PDF
(Eng)
Том 10, № 7 (2010)
Updates of mTOR Inhibitors
Zhou H., Luo Y., Huang S.
PDF
(Eng)
Том 24, № 18 (2024)
Agrimonolide Inhibits the Malignant Progression of Non-small Cell Lung Cancer and Induces Ferroptosis through the mTOR Signaling Pathway
Zhang X., Cai W., Yan Y.
PDF
(Eng)
1 - 31 из 31 результатов
Подсказки:
  • Ключевые слова чувствительны к регистру
  • Английские предлоги и союзы игнорируются
  • По умолчанию поиск проводится по всем ключевым словам (агенс AND экспериенцер)
  • Используйте OR для поиска того или иного термина, напр. образование OR обучение
  • Используйте скобки для создания сложных фраз, напр. архив ((журналов OR конференций) NOT диссертаций)
  • Для поиска точной фразы используйте кавычки, напр. "научные исследования"
  • Исключайте слово при помощи знака - (дефис) или оператора NOT; напр. конкурс -красоты или же конкурс NOT красоты
  • Используйте * в качестве версификатора, напр. научн* охватит слова "научный", "научные" и т.д.